Iasonos Alexia, Wages Nolan A, Conaway Mark R, Cheung Ken, Yuan Ying, O'Quigley John
Memorial Sloan Kettering Cancer Center, New York, NY, U.S.A.
Division of Translational Research and Applied Statistics, Department of Public Health Sciences, University of Virginia, Charlottesville, VA, U.S.A.
Stat Med. 2016 Sep 20;35(21):3760-75. doi: 10.1002/sim.6966. Epub 2016 Apr 18.
Adaptive, model-based, dose-finding methods, such as the continual reassessment method, have been shown to have good operating characteristics. One school of thought argues in favor of the use of parsimonious models, not modeling all aspects of the problem, and using a strict minimum number of parameters. In particular, for the standard situation of a single homogeneous group, it is common to appeal to a one-parameter model. Other authors argue for a more classical approach that models all aspects of the problem. Here, we show that increasing the dimension of the parameter space, in the context of adaptive dose-finding studies, is usually counter productive and, rather than leading to improvements in operating characteristics, the added dimensionality is likely to result in difficulties. Among these are inconsistency of parameter estimates, lack of coherence in escalation or de-escalation, erratic behavior, getting stuck at the wrong level, and, in almost all cases, poorer performance in terms of correct identification of the targeted dose. Our conclusions are based on both theoretical results and simulations. Copyright © 2016 John Wiley & Sons, Ltd.
基于模型的适应性剂量探索方法,如连续重新评估法,已被证明具有良好的操作特性。一种观点主张使用简约模型,即不对问题的所有方面进行建模,而是使用严格最少数量的参数。特别是对于单一同质群体的标准情况,采用单参数模型很常见。其他作者则主张采用更经典的方法,对问题的所有方面进行建模。在此,我们表明,在适应性剂量探索研究的背景下,增加参数空间的维度通常会适得其反,不仅不会改善操作特性,增加的维度还可能导致各种困难。其中包括参数估计的不一致性、剂量递增或递减缺乏连贯性、行为不稳定、在错误水平停滞不前,而且在几乎所有情况下,在正确识别目标剂量方面表现更差。我们的结论基于理论结果和模拟。版权所有© 2016约翰·威利父子有限公司。